You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ipilimumab

Showing 26 - 50 of 914
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

Not yet recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Ipilimumab
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Mar 9, 2023

Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Boston (Nivolumab, Ipilimumab)

Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Oct 18, 2022

Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in Duarte

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Biospecimen Collection
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Sep 19, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Nivolumab, Ipilimumab, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Boston, Massachusetts
  • +2 more
Sep 7, 2022

Melanoma Trial in Washington, Baltimore, Hackensack (Nivolumab, Ipilimumab, Cabozantinib)

Suspended
  • Melanoma
  • Washington, District of Columbia
  • +2 more
Jan 18, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Ipilimumab
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Melanoma Trial in New York (Nivolumab, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Nivolumab
  • Ipilimumab
  • New York, New York
    Laura and Isaac Perlmutter Cancer Center
Aug 11, 2022

Advanced Metastatic Cancer, Advanced Prostate Cancer Trial in United States (Nivolumab Monotherapy, Nivolumab and Ipilimumab and

Active, not recruiting
  • Advanced Metastatic Cancer
  • Advanced Prostate Cancer
  • Nivolumab Monotherapy
  • +3 more
  • Los Angeles, California
  • +5 more
Dec 16, 2022

Locally Advanced or Metastatic Melanoma Trial (CBL0137, Ipilimumab, Nivolumab)

Not yet recruiting
  • Locally Advanced or Metastatic Melanoma
  • (no location specified)
Aug 10, 2022

Breast Tumor Female, Breast Cancer, Breast Carcinoma Trial in Portland (Nivolumab, Ipilimumab, Bicalutamide)

Recruiting
  • Breast Neoplasm Female
  • +3 more
  • New York, New York
  • +1 more
Dec 21, 2022

Cancer, Cancer, Lung, Cancer of Lung Trial in Worldwide (UV1 vaccine + leukine, ipilimumab, nivolumab)

Active, not recruiting
  • Cancer
  • +6 more
  • UV1 vaccine + leukine
  • +2 more
  • Perth, Australia
  • +6 more
Jan 23, 2023

Recurrent Glioblastoma Trial in Brussels (Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV,

Not yet recruiting
  • Recurrent Glioblastoma
  • Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV
  • +2 more
  • Brussels, Belgium
    UZ Brussel
Oct 23, 2023

Metastatic Melanoma Trial in Tampa (drug, procedure, biological)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Ipilimumab
  • +6 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 8, 2022

Pancreatic Cancer Trial in Baltimore (Tadalafil, Pembrolizumab, Ipilimumab)

Recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 23, 2022

Nasopharyngeal Carcinoma Trial in Singapore (Ipilimumab, Nivolumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Singapore, Singapore
    National Cancer Center Singapore
Jul 20, 2022

Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

Not yet recruiting
  • Melanoma Stage IV
  • +3 more
  • (no location specified)
Dec 14, 2022

Melanoma Trial in Toulouse (Nivolumab+Ipilimumab in combination with Anti TNF-a Certolizumab, Nivolumab+Ipilimumab in

Active, not recruiting
  • Melanoma
  • Nivolumab+Ipilimumab in combination with Anti TNF-α Certolizumab
  • Nivolumab+Ipilimumab in combination with Anti TNF-α Infliximab
  • Toulouse, France
    Institut Claudius Regaud IUCT-ONCOPOLE
Nov 18, 2022

NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

Not yet recruiting
  • NSCLC Stage IV
  • +4 more
  • Nivolumab and Ipilimumab
  • Verona, Veneto/Verona, Italy
    Centro Ricerche Cliniche
Oct 26, 2022

Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma, Uterine Corpus Leiomyosarcoma Trial in Boston (Ipilimumab, Laboratory

Active, not recruiting
Has Results
  • Metastatic Leiomyosarcoma
  • +2 more
  • Ipilimumab
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Unresectable or Metastatic Melanoma Trial in Australia, United States (Ipilimumab, NY-ESO-1 Protein Vaccine, NY-ESO-1 OLP4

Terminated
Has Results
  • Unresectable or Metastatic Melanoma
  • Ipilimumab
  • +3 more
  • New York, New York
  • +4 more
Oct 3, 2022

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Chicago, Providence (Nivolumab, Ipilimumab)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Chicago, Illinois
  • +3 more
Jan 26, 2023

Metastatic Urothelial Carcinoma Trial in Tampa, Boston (Ipilimumab, Nivolumab, Sacituzumab govitecan)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Ipilimumab
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Breast Cancer Trial in Los Angeles, Portland (Ipilimumab, Nivolumab, Core Biopsy/Cryoablation)

Recruiting
  • Breast Cancer
  • Ipilimumab
  • +3 more
  • Los Angeles, California
  • +2 more
Sep 27, 2022

Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Trial in Cleveland (TQ Formula (black

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Gastroenteropancreatic Neuroendocrine Neoplasm
  • TQ Formula (black seed oil capsules)
  • +2 more
  • Cleveland, Ohio
    University hospitals Seidman Cancer Center, Case Comprehensive C
Aug 12, 2022